Cargando…

Virtual Lead Identification of Farnesyltransferase Inhibitors Based on Ligand and Structure-Based Pharmacophore Techniques

Farnesyltransferase enzyme (FTase) is considered an essential enzyme in the Ras signaling pathway associated with cancer. Thus, designing inhibitors for this enzyme might lead to the discovery of compounds with effective anticancer activity. In an attempt to obtain effective FTase inhibitors, pharma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Balas, Qosay A., Amawi, Haneen A., Hassan, Mohammad A., Qandil, Amjad M., Almaaytah, Ammar M., Mhaidat, Nizar M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816728/ https://www.ncbi.nlm.nih.gov/pubmed/24276257 http://dx.doi.org/10.3390/ph6060700

Ejemplares similares

Generation of the First Structure-Based Pharmacophore Model Containing a Selective “Zinc Binding Group” Feature to Identify Potential Glyoxalase-1 Inhibitors
por: Al-Balas, Qosay, et al.
Publicado: (2012)

Novel N-substituted aminobenzamide scaffold derivatives targeting the dipeptidyl peptidase-IV enzyme
por: Al-Balas, Qosay A, et al.
Publicado: (2014)

Novel glyoxalase-I inhibitors possessing a “zinc-binding feature” as potential anticancer agents
por: Al-Balas, Qosay A, et al.
Publicado: (2016)

Synthesis, Antibacterial Evaluation and QSAR of α-Substituted-N(4)-Acetamides of Ciprofloxacin and Norfloxacin
por: Qandil, Amjad M., et al.
Publicado: (2014)

A3, a Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug Resistant Gram Positive Bacteria
por: Almaaytah, Ammar, et al.
Publicado: (2018)

Peptide consensus sequence determination for the enhancement of the antimicrobial activity and selectivity of antimicrobial peptides
por: Almaaytah, Ammar, et al.
Publicado: (2016)

Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria
por: Almaaytah, Ammar, et al.
Publicado: (2017)

Potassium-3-beta-hydroxy-20-oxopregn-5-en-17-alpha-yl sulfate: a novel inhibitor of 78 kDa glucose-regulated protein
por: Mhaidat, Nizar M, et al.
Publicado: (2016)

Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking
por: Audat, Suaad A., et al.
Publicado: (2020)

Enhanced Antimicrobial Activity of AamAP1-Lysine, a Novel Synthetic Peptide Analog Derived from the Scorpion Venom Peptide AamAP1
por: Almaaytah, Ammar, et al.
Publicado: (2014)

Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides
por: Almaaytah, Ammar, et al.
Publicado: (2018)

Multi-Armed 1,2,3-Selenadiazole and 1,2,3-Thiadiazole Benzene Derivatives as Novel Glyoxalase-I Inhibitors
por: Al-Balas, Qosay A., et al.
Publicado: (2019)

Synthesis, antimicrobial and in vitro antitumor activities of a series of 1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives
por: Mhaidat, Nizar M, et al.
Publicado: (2015)

In vivo antimicrobial activity of the hybrid peptide H4: a follow-up study
por: Almaaytah, Ammar, et al.
Publicado: (2018)

Antimicrobial and Antibiofilm Activity of UP-5, an Ultrashort Antimicrobial Peptide Designed Using Only Arginine and Biphenylalanine
por: Almaaytah, Ammar, et al.
Publicado: (2018)

Pharmacophore and docking-based sequential virtual screening for the identification of novel Sigma 1 receptor ligands
por: Alamri, Mubarak A, et al.
Publicado: (2019)

Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures
por: Kutlushina, Alina, et al.
Publicado: (2018)

Targeting Dengue Virus NS-3 Helicase by Ligand based Pharmacophore Modeling and Structure based Virtual Screening
por: Halim, Sobia A., et al.
Publicado: (2017)

Ligand Based Pharmacophore Modeling and Virtual Screening Studies to Design Novel HDAC2 Inhibitors
por: Kandakatla, Naresh, et al.
Publicado: (2014)

Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases
por: Kaserer, Teresa, et al.
Publicado: (2015)

Selective ligands of estrogen receptor β discovered using pharmacophore mapping and structure-based virtual screening
por: Chen, Lei, et al.
Publicado: (2014)

Ligand-based pharmacophore modeling, virtual screening and biological evaluation to identify novel TGR5 agonists
por: Zhao, Shizhen, et al.
Publicado: (2021)

Probabilistic Approach for Virtual Screening Based on Multiple Pharmacophores
por: Madzhidov, Timur I., et al.
Publicado: (2020)

Ligand-Based Pharmacophore Modeling and Virtual Screening for the Discovery of Novel 17β-Hydroxysteroid Dehydrogenase 2 Inhibitors
por: Vuorinen, Anna, et al.
Publicado: (2014)

Identification of Novel HIV 1- Protease Inhibitors: Application of Ligand and Structure Based Pharmacophore Mapping and Virtual Screening
por: Yadav, Divya, et al.
Publicado: (2012)

Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors
por: Pal, Sourav, et al.
Publicado: (2019)

Integrative Ligand-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Simulation Approaches Identified Potential Lead Compounds against Pancreatic Cancer by Targeting FAK1
por: Molla, Mohammad Habibur Rahman, et al.
Publicado: (2023)

PharmaGist: a webserver for ligand-based pharmacophore detection
por: Schneidman-Duhovny, Dina, et al.
Publicado: (2008)

Molecular docking, pharmacophore based virtual screening and molecular dynamics studies towards the identification of potential leads for the management of H. pylori
por: Damale, Manoj G., et al.
Publicado: (2019)

The ethics of practicing defensive medicine in Jordan: a diagnostic study
por: Al-Balas, Qosay A. E., et al.
Publicado: (2021)

Identification of novel leads as potent inhibitors of HDAC3 using ligand-based pharmacophore modeling and MD simulation
por: Kumbhar, Navanath, et al.
Publicado: (2022)

Bacteria Are New Targets for Inhibitors of Human Farnesyltransferase
por: Weber, Lea, et al.
Publicado: (2021)

Discovery of YopE Inhibitors by Pharmacophore-Based Virtual Screening and Docking
por: Ozbuyukkaya, Gizem, et al.
Publicado: (2013)

In-silico protein-ligand docking studies against the estrogen protein of breast cancer using pharmacophore based virtual screening approaches
por: Sahayarayan, Jesudass Joseph, et al.
Publicado: (2021)

A Combination of Pharmacophore-Based Virtual Screening, Structure-Based Lead Optimization, and DFT Study for the Identification of S. epidermidis TcaR Inhibitors
por: Vuppala, Srimai, et al.
Publicado: (2022)

Lead identification and optimization of novel collagenase inhibitors; pharmacophore and structure based studies
por: Kalva, Sukesh, et al.
Publicado: (2012)

Ligand-based pharmacophore modeling and QSAR approach to identify potential dengue protease inhibitors
por: Poola, Anushka A., et al.
Publicado: (2023)

Assessing the efficacy of protein farnesyltransferase inhibitors in mouse models of progeria
por: Yang, Shao H., et al.
Publicado: (2010)

New targets for therapy in breast cancer: Farnesyltransferase inhibitors
por: Head, Julia, et al.
Publicado: (2004)

Engineering Protein Farnesyltransferase for Enzymatic Protein Labeling Applications
por: Dozier, Jonathan K., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_srdfgrdijbrsdtdcvpeih6ual9